Inventor profile of:

Norbert BEIER

City:

Reinheim

Country:

Germany

Published Applications:

44

Last publication date:

2017-07-06

Top Assignees for applications by Norbert BEIER

The entities that hold a legal rights for patent applications filed by inventor BEIER Norbert:

Recent patent applications by BEIER Norbert

Norbert BEIER from Reinheim, DE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2017-07-06
US20170189354A1
Human necessities

Pharmaceutical composition comprising rimeporide for treating diseases associated with insulin resistance and β-cell dysfunction

#2 | 2011-09-15
US20110224302A1
Chemistry; metallurgy

Difluorophenyldiacylhydrazide derivatives

#3 | 2011-08-11
US20110195991A1
Chemistry; metallurgy

3-aminoimidazo [1,2-A] pyridine derivatives as SGLT inhibitors

#4 | 2011-08-04
US20110190355A1
Chemistry; metallurgy

Heterocyclic indazole derivatives

#5 | 2011-06-16
US20110139654A1
Chemistry; metallurgy

Oxadiazole derivatives for the treatment of diabetes

#6 | 2011-03-10
US20110060051A1
Human necessities

PHARMACEUTICAL COMPOSITION COMPRISING RIMEPORIDE FOR TREATING DISEASES ASSOCIATED WITH INSULIN RESISTANCE AND BETA-CELL DYSFUNCTION

#7 | 2011-03-10
US20110060050A1
Chemistry; metallurgy

SGK1 inhibitors for the prophylaxis and/or therapy of viral diseases and/or carcinomas

#8 | 2011-02-03
US20110028414A1
Chemistry; metallurgy

Glucopyranoside derivatives

#9 | 2011-01-13
US20110009455A1
Chemistry; metallurgy

5-oxo-2,3,4,5-tetrahydro-benzo[b]oxepine-4-carboxylic acid amides and 2,3-dihydro-benzo[b]oxepine-4-carboxylic acid amides for treatment and prevention of diabetes typ 1 and 2

#10 | 2011-01-13
US20110009437A1
Chemistry; metallurgy

CARBOXAMIDE-HETEROARYL DERIVATIVES FOR THE TREATMENT OF DIABETES

#11 | 2010-12-30
US20100331346A1
Chemistry; metallurgy

Beta-amino acid derivatives for treatment of diabetes

#12 | 2010-12-30
US20100331338A1
Chemistry; metallurgy

Glucokinase Activators

#13 | 2010-12-02
US20100305142A1
Chemistry; metallurgy

3-aminoimidazo 1,2-A pyridine derivatives having an SGLT1- and SGLT2-inhibiting action for the treatment of type 1 and type 2 diabetes

#14 | 2010-09-30
US20100249151A1
Chemistry; metallurgy

Imidazo 1,2-pyrimidine derivatives for the treatment of diseases such as diabetes

#15 | 2010-08-26
US20100216794A1
Chemistry; metallurgy

Pyridine derivatives useful as glucokinase activators

#16 | 2010-08-19
US20100210690A1
Chemistry; metallurgy

N-(pyrazole-3-yl)-benzamide derivatives as glucokinase activators

#17 | 2010-03-11
US20100063115A1
Chemistry; metallurgy

5-(1,3,4-OXADIAZOL-2-YL)-1H-INDAZOLE AND 5-(1,3,4-THIADIAZOL-2-YL)-1H-INDAZOLE DERIVATIVES AS SGK INHIBITORS FOR THE TREATMENT OF DIABETES

#18 | 2010-02-11
US20100035915A1
Chemistry; metallurgy

Indolizine derivatives and the use thereof as antidiabetics

#19 | 2010-01-21
US20100016372A1
Chemistry; metallurgy

Benzimidazole derivatives

#20 | 2009-10-08
US20090253767A1
Chemistry; metallurgy

Aminoindazolylurea derivatives

#21 | 2009-09-03
US20090221712A1
Chemistry; metallurgy

Mandelic hydrazides

#22 | 2009-03-19
US20090076091A1
Chemistry; metallurgy

Indazole-heteroaryl derivatives

#23 | 2009-02-05
US20090036508A1
Chemistry; metallurgy

AMINO INDAZOLE DERIVATIVES

#24 | 2009-02-05
US20090036449A1
Chemistry; metallurgy

Indazolesquaric Acid Derivatives as Chk1, Chk2 and Sgk Inhibitors

#25 | 2009-02-03
US10484172
-

4-(benzylidene-amino)-3-(methylsulfanyl)-4h-(1,2,4)triazin-5-one derivatives having a PDE-IV inhibiting and TNF-antagonistic effect for the treatment of cardiac diseases and allergies

#26 | 2008-10-23
US20080262096A1
Chemistry; metallurgy

Squaric Acid Derivatives

#27 | 2008-09-25
US20080234348A1
Chemistry; metallurgy

3-Oxoindazolesquaric Acid Derivatives

#28 | 2008-09-04
US20080214674A1
Chemistry; metallurgy

ACYLHYDRAZONE DERIVATIVES AND THE USE THEREOF IN THE INHIBITION, REGULATION AND/OR MODULATION OF KINASE SIGNAL TRANSDUCTION

#29 | 2008-07-10
US20080167380A1
Chemistry; metallurgy

Acyl hydrazines as kinase inhibitors, in particular for SGK

#30 | 2008-04-17
US20080090882A1
Human necessities

Heterocyclic carbonyl compounds

#31 | 2008-02-07
US20080032983A1
Chemistry; metallurgy

Ortho-substituted N'-benzylidene-(3-hydroxyphenyl)acethydrazides

#32 | 2007-12-25
US10491680
-

Pyrimidine derivatives

#33 | 2007-12-25
US10451393
-

Benzoylpyridazines

#34 | 2007-10-04
US20070232620A1
Chemistry; metallurgy

3-aminoindazoles

#35 | 2007-08-21
US10312767
-

2-Aminoalkyl-thieno[2,3-d]pyrimidines

#36 | 2007-03-15
US20070060646A1
Chemistry; metallurgy

Acylhydrazone derivatives and the use thereof in the inhibition, regulation and/or modulation of kinase signal transduction

#37 | 2006-11-30
US20060270676A1
Chemistry; metallurgy

Hydrazono-malonitriles

#38 | 2006-11-28
US10494631
-

Hydrazono-malonitriles

#39 | 2006-09-14
US20060205708A1
Chemistry; metallurgy

Aryl oximes

#40 | 2006-06-13
US10312766
-

5-aminoalkyl-pyrazolo[4,3-d]pyrimidines with a phosphodiesterase v-inhibiting effect

#41 | 2006-03-28
US10451183
-

Sulfamidothienopyrimidines

#42 | 2005-09-22
US20050209240A1
Chemistry; metallurgy

Aryl oximes

#43 | 2005-05-26
US20050113396A1
Chemistry; metallurgy

2-Guanidino-4-heterocyclylquinazolines

#44 | 2005-03-31
US20050070529A1
Human necessities

Use of type 4 phosphodiesterase inhibitors in myocardial diseases

InventorID:

1920510 ⎘